MarketInOut Stock Screener Log In | Sign Up
 

Viking Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Viking Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization3,396.58 mln
Float123 mln
Earnings Date10/28/2026

Piotroski F-Score

1 / 9
Very weak

1-Year Forecast

94.10
Transformational upside

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

0.01
Debt-free

ROE

-87.45
Deeply negative

ROA

-78.34
Deeply negative

Business Description

Viking Therapeutics is a San Diego-based company founded in 2012 that researches and develops new medicines targeting hormonal and metabolic diseases. The company has several drugs in clinical testing, addressing conditions such as liver disease, muscle loss following hip fractures, and rare genetic disorders. Its most advanced treatments work by selectively targeting specific receptors in the body, aiming to deliver therapeutic benefits while minimizing unwanted side effects.

Key Fundamentals

EPS-4.67
ROE-87.45
ROIC-38,638
ROA-78.34
Interest Cover-70,003
EBITDA, mln-534
EV / EBITDA-6.73
EV / EBIT-6.72

Quote Details

Last 24.40
Change -1.43 (-5.54%)
Open 25.54
Volume 4,650,482
Turnover 113,471,760
Average Volume 6,120,367

Financial Ratios

Leverage Ratio1.28
Current Ratio4.72
Price / Book9.31
Price / Tangible Book9.31
Debt / Equity0.01

Financial Strength

Piotroski F-Score 1 / 9
1-Year Target Price94.10
Short Ratio3.66
Short % of Float21.44

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -3.06% 22 / 100   
1 Month -33.61% 10 / 100   
2 Months -32.93% 15 / 100   
6 Months -25.5% 23 / 100   
1 Year -22.34% 29 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog